| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
Articles |
Departments of
1
Clinical Chemistry,
2
Nephrology and Rheumatology, and
3
Transplant Surgery, Georg-August-University, Robert-Koch-Strasse 40, 37075 Göttingen, Germany.
aAuthor for correspondence. Fax 49-551-39-12504; e-mail nahsen{at}gwdg.de.
Background: A substantial proportion of the variability in the absorption and clearance of cyclosporin A (CsA) after oral administration has been attributed to variability in liver cytochrome P-450 3A4 (CYP3A4) activity and intestinal P-glycoprotein (P-gp) concentration. A polymorphism in the CYP3A4 promoter region, termed "variant" allele CYP3A4-V, was postulated to be associated with altered CYP3A4 enzyme activity. A polymorphism in exon 26 (C3435T) of the multidrug resistance-1 (MDR-1) gene was correlated with intestinal expression and in vivo activity of P-gp.
Methods: We investigated the occurrence of both polymorphisms in 124 stable Caucasian renal transplant recipients (>6 months after transplantation) on CsA as the primary immunosuppressant. Real-time, rapid-cycle PCR methods were developed and used for genotyping.
Results: The estimated allele frequencies for the MDR-1 C3435T allele (54%) and the CYP3A4-V allele (4.8%) were similar to those reported for Caucasian populations. No significant differences were found for the CsA doses needed to maintain similar CsA trough concentrations in patients with and without the CYP3A4-V allele or in patients with different MDR-1 C3435T genotypes. Furthermore, neither of the polymorphisms investigated was associated with renal function as assessed by creatinine plasma concentration or, in a retrospective analysis, the incidence of acute rejection.
Conclusions: These findings suggest that the MDR-1 C3435T mutation and the CYP3A4-V variant are not major determinants of CsA efficacy in renal transplant recipients.
The following articles in journals at HighWire Press have cited this article:
|
|
 |
|
  B. H. Rovin, A. M. McKinley, and D. J. Birmingham Can We Personalize Treatment for Kidney Diseases? Clin. J. Am. Soc. Nephrol., October 1, 2009; 4(10): 1670 - 1676. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Cotte, N. von Ahsen, N. Kruse, B. Huber, A. Winkelmann, U. K. Zettl, M. Starck, N. Konig, N. Tellez, J. Dorr, et al. ABC-transporter gene-polymorphisms are potential pharmacogenetic markers for mitoxantrone response in multiple sclerosis Brain, September 1, 2009; 132(9): 2517 - 2530. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. S. Joy, M. La, and Bo Xiao Individualizing Therapy in Patients With Chronic Kidney Disease Journal of Pharmacy Practice, June 1, 2008; 21(3): 225 - 236. [Abstract] [PDF]
|
|
|
|
 |
|
 P. Bolufer, M. Collado, E. Barragan, J. Cervera, M.-J. Calasanz, D. Colomer, J. Roman-Gomez, and M. A. Sanz The potential effect of gender in combination with common genetic polymorphisms of drug-metabolizing enzymes on the risk of developing acute leukemia Haematologica, March 1, 2007; 92(3): 308 - 314. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. Couture, J. A. Nash, and J. Turgeon The ATP-Binding Cassette Transporters and Their Implication in Drug Disposition: A Special Look at the Heart. Pharmacol. Rev., June 1, 2006; 58(2): 244 - 258. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S.-J. Lee, W. J. Jusko, C. G. Salaita, K. A. Calis, M. W. Jann, V. E. Spratlin, J. A. Goldstein, and Y. Y. Hon Reduced Methylprednisolone Clearance Causing Prolonged Pharmacodynamics in a Healthy Subject Was Not Associated With CYP3A5*3 Allele or a Change in Diet Composition. J. Clin. Pharmacol., May 1, 2006; 46(5): 515 - 526. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 I. A. Hauser, E. Schaeffeler, S. Gauer, E. H. Scheuermann, B. Wegner, J. Gossmann, H. Ackermann, C. Seidl, B. Hocher, U. M. Zanger, et al. ABCB1 Genotype of the Donor but Not of the Recipient Is a Major Risk Factor for Cyclosporine-Related Nephrotoxicity after Renal Transplantation J. Am. Soc. Nephrol., May 1, 2005; 16(5): 1501 - 1511. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. S. Putnam, J. M. Woo, Y. Huang, and L. Z. Benet Effect of the MDR1 C3435T Variant and P-Glycoprotein Induction on Dicloxacillin Pharmacokinetics J. Clin. Pharmacol., April 1, 2005; 45(4): 411 - 421. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. D. Baker, R. H. N. van Schaik, L. P. Rivory, A. J. ten Tije, K. Dinh, W. J. Graveland, P. W. Schenk, K. A. Charles, S. J. Clarke, M. A. Carducci, et al. Factors Affecting Cytochrome P-450 3A Activity in Cancer Patients Clin. Cancer Res., December 15, 2004; 10(24): 8341 - 8350. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. L. Woodahl, Z. Yang, T. Bui, D. D. Shen, and R. J. Y. Ho Multidrug Resistance Gene G1199A Polymorphism Alters Efflux Transport Activity of P-Glycoprotein J. Pharmacol. Exp. Ther., September 1, 2004; 310(3): 1199 - 1207. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
I. Mai, E. Stormer, M. Goldammer, A. Johne, H. Kruger, K. Budde, and I. Roots MDR1 Haplotypes Do Not Affect the Steady-State Pharmacokinetics of Cyclosporine in Renal Transplant Patients J. Clin. Pharmacol., October 1, 2003; 43(10): 1101 - 1107. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Anglicheau, C. Verstuyft, P. Laurent-Puig, L. Becquemont, M.-H. Schlageter, B. Cassinat, P. Beaune, C. Legendre, and E. Thervet Association of the Multidrug Resistance-1 Gene Single-Nucleotide Polymorphisms with the Tacrolimus Dose Requirements in Renal Transplant Recipients J. Am. Soc. Nephrol., July 1, 2003; 14(7): 1889 - 1896. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. R. Yates, W. Zhang, P. Song, S. Li, A. O. Gaber, M. Kotb, M. R. Honaker, R. R. Alloway, and B. Meibohm The Effect of CYP3A5 and MDR1 Polymorphic Expression on Cyclosporine Oral Disposition in Renal Transplant Patients J. Clin. Pharmacol., June 1, 2003; 43(6): 555 - 564. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R O. Elferink Cholestasis Gut, May 1, 2003; 52(90002): ii42 - 48. [Abstract] [Full Text]
|
|
|
|
 |
|
 P.-C. Gwee, K. Tang, J. M.Z. Chua, E. J.D. Lee, S. S. Chong, and C. G.L. Lee Simultaneous Genotyping of Seven Single-Nucleotide Polymorphisms in the MDR1 Gene by Single-Tube Multiplex Minisequencing Clin. Chem., April 1, 2003; 49(4): 672 - 676. [Full Text] [PDF]
|
|
|
|
|
|
T. Nozawa, M. Nakajima, I. Tamai, K. Noda, J.-i. Nezu, Y. Sai, A. Tsuji, and T. Yokoi Genetic Polymorphisms of Human Organic Anion Transporters OATP-C (SLC21A6) and OATP-B (SLC21A9): Allele Frequencies in the Japanese Population and Functional Analysis J. Pharmacol. Exp. Ther., August 1, 2002; 302(2): 804 - 813. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
